@article{df12c1433876458e9efbec6b8ca62544,
title = "Editorial: Wnt signaling in endocrine and metabolic disorders",
keywords = "Alzheimer{\textquoteright}s disease, Wnt, Wnt/b-catenin, cancer, endocrinology, endocrinology & metabolism, metabolism, microRNA",
author = "Frederic Cailotto and Gaetano Santulli",
note = "Funding Information: The Santulli Lab is supported in part by the National Institutes of Health (NIH) (the National Heart, Lung, and Blood Institute [NHLBI: R01-HL164772, R01-HL159062, R01-HL146691, and T32-HL144456 to GS] and the National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK: R01-DK123259 and R01-DK033823 to GS]); the National Center for Advancing Translational Sciences (NCATS: UL1-TR002556-06 to GS); the Diabetes Action Research and Education Foundation (to GS); and the Monique Weill-Caulier and Irma T. Hirschl Trusts (to GS). FC is supported by grants from the Fondation pour la Recherche M{\'e}dicale (FRM, n° REP202210016152). ",
year = "2023",
doi = "10.3389/fendo.2023.1254977",
language = "English (US)",
volume = "14",
journal = "Frontiers in Endocrinology",
issn = "1664-2392",
publisher = "Frontiers Media S. A.",
}
